Dow Gordon, MacLaggan Timothy, Allard Jacques
Division of Infectious Diseases, The Moncton Hospital, Horizon Health Network, Moncton, New Brunswick, Canada.
J Assoc Med Microbiol Infect Dis Can. 2022 Sep 27;7(3):196-207. doi: 10.3138/jammi-2022-0004. eCollection 2022 Sep.
Bloodstream infections (BSIs) in hospitalized patients represent sentinel events requiring timely and responsive antimicrobial prescribing. These infections represent an attractive but seldom-evaluated stewardship opportunity.
Retrospective pre-post study design, with review of patient charts 18 months before and after initiation of a hospital Bloodstream Infection Stewardship Program (BSISP). Pre-intervention, the ward and attending physician were notified of all positive blood cultures. Post-intervention, an infectious disease (ID) pharmacist collaborating with an ID consultant was also notified.
Two hundred twenty-six eligible BSIs were identified pre-intervention and 195 post-intervention. The urinary tract was the most common source of infection; most common bloodstream isolates were , , beta-hemolytic streptococci, and ; 71.7% of infections were community acquired. Empiric therapy was not given in 17.3% of cases and inadequate in 16.4% of patients. Therapy was altered on the basis of Gram stain results ('directed therapy') in 54.6% of episodes and was inadequate in 3.5%. Compared to pre-intervention, the post-intervention cohort received directed therapy on average 4.36 hours earlier ( = 0.003), was more likely to receive appropriate definitive therapy (99.0% post versus 79.1% pre, <0.001), stepped down to oral therapy earlier (6.0 versus 8.0 days, = 0.031), and received fewer directed prescriptions (214 per 100 cases post versus 260 per 100 cases pre; = 0.001), including fewer prescriptions of quinolones and clindamycin.
A BSISP could be an effective strategy for improving antimicrobial prescribing in hospitalized patients with a BSI.
住院患者的血流感染(BSIs)是需要及时且合理使用抗菌药物的标志性事件。这些感染是一个有吸引力但很少被评估的管理机会。
回顾性前后对照研究设计,对医院血流感染管理项目(BSISP)启动前18个月和启动后18个月的患者病历进行审查。干预前,所有血培养阳性结果会通知病房和主治医生。干预后,还会通知一名与感染病(ID)顾问合作的ID药剂师。
干预前确定了226例符合条件的BSIs,干预后为195例。泌尿道是最常见的感染源;最常见的血流分离菌是[此处原文缺失具体细菌名称]、[此处原文缺失具体细菌名称]、β溶血性链球菌和[此处原文缺失具体细菌名称];71.7%的感染是社区获得性的。17.3%的病例未给予经验性治疗,16.4%的患者治疗不充分。54.6%的病例根据革兰氏染色结果改变治疗方案(“针对性治疗”),其中3.5%治疗不充分。与干预前相比,干预后队列平均提前4.36小时接受针对性治疗(P = 0.003),更有可能接受合适的确定性治疗(干预后为99.0%,干预前为79.1%,P<0.001),更早过渡到口服治疗(分别为6.0天和8.0天,P = 0.031),并且接受的针对性处方更少(干预后每100例病例214张,干预前每100例病例260张;P = 0.001),包括喹诺酮类和克林霉素的处方更少。
BSISP可能是改善住院BSI患者抗菌药物使用的有效策略。